GKSSL H1 FY27 IPD revenue overtakes FY26 at 55% occupancy

Gujarat Kidney & Superspeciality Hospital (GKSSL) reported Rs 61.08 crore of inpatient department (IPD) revenue in the first half (H1) of financial year (FY) 27, exceeding its Rs 47.53 crore full-year FY26 total by Rs 13.55 crore, while average bed-days occupancy was 55%, against 56% in FY26.

How did GKSSL’s H1 FY27 IPD revenue compare with FY26?

GKSSL’s H1 FY27 IPD revenue was higher than its FY26 full-year revenue, reaching Rs 61.08 crore from 11,040 IPD cases, compared with Rs 47.53 crore from 13,281 cases in FY26. The H1 FY27 revenue total was Rs 13.55 crore above the preceding full year, although the reported case count was 2,241 lower.

IPD revenue rose from Rs 33.0095 crore in FY25 to Rs 47.53 crore in FY26 before reaching Rs 61.08 crore in H1 FY27. IPD volume increased from 5,704 cases in FY25 to 13,281 in FY26, while the H1 FY27 count of 11,040 was close to the FY26 full-year level.

H1 FY27 occupied bed days were 66,240, equal to 83% of FY26’s 79,686 occupied bed days, while H1 IPD revenue exceeded the FY26 full-year total. The presentation does not provide a separate breakdown by procedure, hospital, payer category or specialty to explain the difference between revenue and case volumes.

Did GKSSL’s bed occupancy improve in H1 FY27?

No, GKSSL reported average bed-days occupancy of 55% in H1 FY27, compared with 56% in FY26 and 54% in both FY24 and FY25. The H1 reading was one percentage point below FY26 despite 66,240 occupied bed days during the half year.

Average length of stay was unchanged at 6.00 days in every reported period from FY24 through H1 FY27. This was recorded alongside IPD volume growth from 489 cases in FY24 to 5,704 in FY25 and 13,281 in FY26, with 11,040 cases in H1 FY27.

Average revenue per occupied bed day fell to Rs 9,221 in H1 FY27 from Rs 10,255 in FY26. The measure was Rs 9,417 in FY25 and Rs 9,305 in FY24, meaning total IPD revenue rose to Rs 61.08 crore in H1 FY27 even as reported occupancy and revenue per occupied bed day were below FY26 levels.

How did GKSSL’s outpatient business perform in H1 FY27?

GKSSL’s outpatient department (OPD) revenue reached Rs 15.55 crore in H1 FY27 from 78,643 visits, exceeding the Rs 11.7908 crore reported from 95,876 visits in FY26. H1 FY27 OPD revenue was therefore Rs 3.7592 crore above the prior full-year amount, although visits were 17,233 lower.

OPD activity expanded from 1,533 visits and Rs 32.18 lakh of revenue in FY24 to 38,492 visits and Rs 7.7932 crore in FY25. FY26 then recorded 95,876 visits and Rs 11.7908 crore of OPD revenue, followed by Rs 15.55 crore in H1 FY27.

Both the OPD and IPD data show H1 FY27 revenue above FY26 full-year revenue. The presentation does not specify whether pricing, specialty mix, hospital additions or another factor drove this change, but it describes an asset-light operating model using leased and controlled facilities across four cities in central Gujarat.

What operational measures is GKSSL planning?

GKSSL plans to improve efficiency through standardized consumables, optimized procurement, supplier consolidation and group-wide purchasing across its hospital network. Management says centralized procurement is intended to reduce sourcing redundancies and costs while supporting competitive patient pricing.

Management also plans to deploy advanced medical equipment, including a Stryker orthopaedic robot, which it says is intended to improve clinical precision, case mix and revenue per occupied bed. GKSSL is additionally exploring tie-ups with small nursing homes to provide diagnostic, operative and staffing support, extending reach and seeking to optimize resource use.

GKSSL says acquisitions completed in FY2024-25 included Gujarat Kidney Hospital, Gujarat Multispeciality Hospital, Surya Hospital & ICU, Gujarat Surgical Hospital, Ashwini Healthcare, and 51% stakes in Raj Palamol Hospital Pvt. Ltd. and Harmony Medicare Private Limited. Its hospital list includes Raj Palmland Hospital in Bharuch, Surya Hospital in Borsad and Ashwini Medical Centre in Anand, all identified by management for upgrades or service expansion.

Which specialties and locations does GKSSL plan to expand?

GKSSL plans to strengthen urology, nephrology, interventional cardiology and oncology across its hospitals. Management says it intends to upgrade Raj Palmland Hospital, Surya Hospital and Ashwini Medical Centre by developing super-speciality departments and expanding their service offerings.

The planned infrastructure includes renal transplant units, three-dimensional imaging for urology and interventional cardiology departments at key hospitals. The equipment programme also covers laser systems, cardiac catheterisation laboratories, laparoscopic and endoscopic instruments, and an in-vitro fertilisation laboratory, although the presentation provides no expenditure amount, completion date or H1 FY27 revenue contribution for individual projects.

GKSSL holds a 51% stake in Blue Tree Clinics in Dubai, while the remaining 49% stake is described as being in the process of acquisition. The clinic generated 5.1 million United Arab Emirates dirhams (AED) in revenue from January 2026 to June 2026, and GKSSL presents the platform as a route to international patients and medical-tourism referrals into its specialist network.

Conclusion

GKSSL’s H1 FY27 operating data show IPD revenue of Rs 61.08 crore exceeding FY26’s full-year Rs 47.53 crore total, while OPD revenue of Rs 15.55 crore also exceeded FY26’s Rs 11.7908 crore. This revenue progression occurred with 55% average bed-days occupancy, one percentage point below FY26, and average revenue per occupied bed day of Rs 9,221, below FY26’s Rs 10,255.

The next reported developments to watch are management’s planned Stryker orthopaedic robot deployment, procurement centralisation, nursing-home tie-ups and additions in urology, nephrology, cardiology and oncology. GKSSL also identifies upgrades at Raj Palmland Hospital, Surya Hospital and Ashwini Medical Centre, while the acquisition of Blue Tree Clinics’ remaining 49% stake remains in process.